PHS
SPLK

PFM Health Sciences’s Splunk Inc SPLK Stock Holding History

PFM Health Sciences’s Portfolio SPLK Stock Details SPLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-90,080
Closed -$11.2M – 104
2019
Q1 		$11.2M Buy
+90,080
New +$11.2M 0.25% 77
2017
Q2 		– Sell
-682,657
Closed -$42.5M – 119
2017
Q1 		$42.5M Buy
+682,657
New +$40.8M 1.06% 38
2016
Q4 		– Sell
-653,872
Closed -$38.4M – 120
2016
Q3 		$38.4M Buy
+653,872
New +$39.2M 1.12% 35
2013
Q3 		– Sell
-705,772
Closed -$32.7M – 90
2013
Q2 		$32.7M Buy
+705,772
New +$30.5M 0.68% 36

Other funds holding SPLK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

PFM Health Sciences's SPLK Position: Q2 2019 in Review

PFM Health Sciences sold out of Splunk Inc (SPLK) in Q2 2019, closing a stake of 90,080 shares — an estimated $11.2M sold.

PFM Health Sciences first reported a position in SPLK in Q2 2013 and held it in 4 quarters. The position peaked at $42.5M in Q1 2017. 582 funds tracked by Wall St. Rank hold SPLK as of Q2 2019.

  • PFM Health Sciences reported no remaining Splunk Inc position as of Q2 2019 after selling out during the quarter.
  • PFM Health Sciences sold 90,080 Splunk Inc shares in Q2 2019, an estimated $11.2M.
  • PFM Health Sciences first reported a position in Splunk Inc in Q2 2013 and held it in 4 quarters.
  • PFM Health Sciences's Splunk Inc position peaked at $42.5M in Q1 2017.
  • 582 funds tracked by Wall St. Rank held Splunk Inc as of Q2 2019.

Based on PFM Health Sciences's 13F filing for Q2 2019, filed 14 Aug 2019.